ABSTRACT
Objective To assess utilization of public and private healthcare, related healthcare expenditure, and associated factors for people with type 2 diabetes (T2D) and/or hypertension (HTN) and for people without those conditions in Cambodia.
Methods A cross-sectional household survey.
Settings Five operational districts in Cambodia.
Participants Data was from 2,360 participants aged ≥ 40 years who had used healthcare services at least once in the three months preceding the survey.
Primary and secondary outcome The main variables of interest were the number of healthcare visits and healthcare expenditure in the last three months.
Results The majority of healthcare visits took place in the private sector. Only 22.0% of healthcare visits took place in public healthcare facilities: 21.7% in people with HTN, 37.2% in people with T2D, 34.7% in people with T2D plus HTN, and 18.9% in people without the two conditions (P-value<0.01). In people with T2D and/or HTN, increased public healthcare use was significantly associated with Health Equity Fund (HEF) membership and living in operational districts with community-based care. Furthermore, significant healthcare expenditure reduction was associated with HEF membership and using public healthcare facilities in these populations.
Conclusion Overall public healthcare utilization was relatively low; however, it was higher in people with chronic conditions. HEF membership and community-based care contributed to higher public healthcare utilization among people with chronic conditions. Using public healthcare services regardless of HEF status reduced healthcare expenditure, but the reduction in spending was more noticeable in people with HEF membership. To increase public healthcare utilization among people with T2D and/or HTN, the public healthcare system should further improve care quality, expand social health protection, and expand community-based care for this population. However, these may require more time and resources. One potential strategy in the short run is to partner the private sector with the public sector.
STRENGTHS AND LIMITATIONS OF THIS STUDY
▪ Our study is among the few to examine healthcare utilization and expenditure among people with two major chronic conditions type 2 diabetes (T2D) and/or hypertension (HTN) in Cambodia, in comparison with the people without the two conditions.
▪ The findings in this study provides could inform decision-makers about strategies for T2D and HTN management in Cambodia and similar settings.
▪ Our study is not representative for the national level as most of the study sites we selected were rural or semi-rural.
▪ We only calculated the healthcare expenditure for those who used the service in the three months preceding the study, which cannot be generalized to the target population in the study (people aged 40 years or older).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the Belgian Government through the VLIR-UOS project, the Fourth Funding Agreement (FA4) Programme (2017-2021) between the Belgian Directorate of Development Cooperation and the Institute of Tropical Medicine, Antwerp, and the Horizon2020 Framework Program of the European Union, grant no 825432.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
National Ethics Committee for Human Research (NECHR) and the Institutional Review Board of Institute of Tropical Medicine (Antwerp) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos